Omeros to Present at the 24th Annual Piper Jaffray Health Care Conference

  Omeros to Present at the 24th Annual Piper Jaffray Health Care Conference

PR Newswire

SEATTLE, Nov. 20, 2012

SEATTLE, Nov. 20, 2012 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a
biopharmaceutical company committed to discovering, developing and
commercializing products focused on inflammation, coagulopathies and disorders
of the central nervous system, today announced that Gregory A. Demopulos,
M.D., chairman and chief executive officer, is scheduled to present at the
24^th Annual Piper Jaffray Health Care Conference next week. The presentation
is scheduled for 9:30 a.m. Eastern Time on Tuesday, November 27, 2012.

The presentation will be webcast. The live and archived webcasts can be
accessed on the "Events" page of the Company's website at www.omeros.com.

About Omeros Corporation
Omeros is a clinical-stage biopharmaceutical company committed to discovering,
developing and commercializing products focused on inflammation,
coagulopathies and disorders of the central nervous system. The Company's most
clinically advanced product candidates are derived from its proprietary
PharmacoSurgery‚ĄĘ platform designed to improve clinical outcomes of patients
undergoing a wide range of surgical and medical procedures. Omeros has four
ongoing clinical development programs. Omeros may also have the near-term
capability, through its GPCR program, to add a large number of new drug
targets and their corresponding compounds to the market. Behind its clinical
candidates and GPCR platform, Omeros is building a diverse pipeline of protein
and small-molecule preclinical programs targeting inflammation, bleeding and
central nervous system disorders.

SOURCE Omeros Corporation

Website: http://www.omeros.com
Contact: Investor and Media Relations, Jennifer Cook Williams, Cook Williams
Communications, Inc., +1.360.668.3701, jennifer@cwcomm.org
 
Press spacebar to pause and continue. Press esc to stop.